Yüksel Ürün

Proud to join such inspiring colleagues as an #ESMOAmbassadors
Excited for #ESMO25 and all the new #CancerResearch ahead.
@myesmo.bsky.social

@ptarantinomd.bsky.social ; @yukselurun.bsky.social ; @arndtvogel.bsky.social ; @tiansterzhangmd.bsky.social

Hastalarımıza gerçeği anlatmak.
Ne korku satmak, ne de sahte umut vermek.

Medya, veriyi dürüst anlattığında güç katar. Ama çarpıtılmış grafikler, abartılmış başlıklar, seçilmiş veriler…
Korku yaratır. Umudu kirletir.

Gerçeği savunmak, hastalarımızı korumaktır. Veri konuşsun, biz dinleyelim.

Cancer care often forgets those at the edges: teens, elders, people with rare cancers. Their needs don’t fit the standard path. Fertility, intimacy, body image deserve the same care as the tumor.
@oncoalert.bsky.social @oncoassist.bsky.social

Every patient is first a human being with a name, a story, a dream.
Dignity is part of the treatment.
Never reduce a life to a diagnosis…
@ascocancer.bsky.social
@myesmo.bsky.social
@oncoalert.bsky.social

Proud of our rising star Coşkun and all colleagues. This meta-analysis on PARP inhibitors and thrombosis risk asks the right question for patients.
@oncoalert.bsky.social @myesmo.bsky.social @apccc.bsky.social @drchoueiri.bsky.social @neerajagarwal.bsky.social

“Medice, cura te ipsum”
Doctor, heal yourself.
Even healers burn out.
Rest is not weakness, it is repair.
Caring for others starts with caring for yourself.

@oncoalert.bsky.social @oncbrothers.bsky.social @ascocancer.bsky.social @myesmo.bsky.social

Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting - OncoDaily Dr. Yüksel Ürün at VIRO 2025 shares insights on personalizing frontline kidney cancer treatment, emphasizing biology and patient-centered care.

Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting

@yukselurun.bsky.social

oncodaily.com/pulse/dr-yuk...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #VIRO #VIRO25

Join Us for Global Voices in Renal Oncology Virtual Congress 2025

@yukselurun.bsky.social

oncodaily.com/pulse/global...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Global voices, shared hope.
Excited to join colleagues at VIRO 2025—working together for patients in renal cancer.

#OncoDaily #VIRO2025
@oncodaily.bsky.social
docs.google.com/forms/d/e/1F...

🌍 𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗼𝗶𝗰𝗲𝘀 𝗶𝗻 𝗥𝗲𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗩𝗜𝗥𝗢) 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀
📅 Sept 11–12, 2025 | 🩺 Chaired by Dr. Rana McKay & co-chaired by Dr. Yüksel Ürün
@yukselurun.bsky.social

🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲: forms.gle/qcQyaGMQfHDh...

oncodaily.com/pulse/rana-m...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd

Yüksel Ürün: Meet the Experts of VIRO 2025 Prof. Yüksel Ürün is a distinguished Professor of Medical Oncology at Ankara University School of Medicine and one of Turkey’s leading experts in

Meet the Experts of VIRO 2025 - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/pulse/yuksel...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Yüksel Ürün: Liquid Biopsy Is No Longer the Future - OncoDaily Yüksel Ürün: Liquid Biopsy Is No Longer the Future / Antonio Alcaraz, Benjamin L Maughan, cancer, Emmanuel S Antonarakis, genitourinary malignancies, Lars

Liquid Biopsy Is No Longer the Future - Yüksel Ürün

@yukselurun.bsky.social
@neerajagarwal.bsky.social
@euplatinum.bsky.social

oncodaily.com/science/liqu...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LiquidBiopsy

Yüksel Ürün: Cancer Prevention is the Quiet Revolution - OncoDaily Yüksel Ürün: Cancer Prevention is the Quiet Revolution / cancer, Cancer Prevention, Cancer research, OncoDaily, Oncology, Yüksel Ürün

Cancer Prevention is the Quiet Revolution - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/voices/yukse...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Every patient teaches me something new about strength, hope, and why we fight.

Yüksel Ürün: Science Is Better When It’s Shared - OncoDaily Yüksel Ürün: Science Is Better When It’s Shared / cancer, Headlines, OncoDaily, Oncology, Yüksel Ürün

Science Is Better When It’s Shared - Yüksel Ürün
@yukselurun.bsky.social

oncodaily.com/blog/science...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Science

Yüksel Ürün: Breast Cancer Care Shouldn’t Be a Luxury - OncoDaily Yüksel Ürün: Breast Cancer Care Shouldn’t Be a Luxury / Amal Arahmani, Ander Urruticoechea, Ankara University School of Medicine, Barbro Lindholm, Boon H.

Breast Cancer Care Shouldn’t Be a Luxury - Yüksel Ürün
@yukselurun.bsky.social

oncodaily.com/insight/yuks...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer

This sounds like an exciting step forward! How soon do you think cancer vaccines like these could become more widely used?

Yüksel Ürün: A Promising Option for Non–Clear-Cell Renal Cell Carcinoma - OncoDaily Yüksel Ürün: A Promising Option for Non–Clear-Cell Renal Cell Carcinoma / cancer, Craig Gedye, Cristina Suárez, David Pook, Erhan Gokmen, european urology,

A Promising Option for Non–Non-Clear-Cell Renal Cell Carcinoma - Yüksel Ürün
@yukselurun.bsky.social
@euplatinum.bsky.social

oncodaily.com/science/yuks...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #nccRCC #KidneyCancer

Yüksel Ürün: How Should We Treat mCRPC and HRR Deficiency? - OncoDaily Yüksel Ürün: How Should We Treat mCRPC and HRR Deficiency? / Ankara University School of Medicine, cancer, HRR Deficiency, mCRPC, metastatic

How Should We Treat mCRPC and HRR Deficiency? - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/blog/how-sho...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #mCRPC #HRR #ProstateCancer

Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC - OncoDaily Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC / ADCs, Biokin Pharma, BMS, cancer, Minhua Chu, OncoDaily, Oncology, Paolo Tarantino,

First Positive Phase 3 Trial for a Bispecific ADC - Paolo Tarantino
@ptarantinomd.bsky.social
@yukselurun.bsky.social

oncodaily.com/insight/paol...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADC

Cancer vaccines: the next frontier is now.
From HBV & HPV to personalized mRNA shots
@oncoalert.bsky.social @oncoassist.bsky.social @ptarantinomd.bsky.social @drchoueiri.bsky.social @viveksubbiah.bsky.social

Take care of your kidneys, protect your life.
4 simple actions = less risk, better outcomes:
🚭 Quit smoking
⚖️ Stay at a healthy weight
🏃‍♀️ Be active, avoid trauma
💧 Drink water, skip alcohol
Because prevention is power
@oncoalert.bsky.social
@drchoueiri.bsky.social @kidneycan.bsky.social

🎗 Gerçek bilim bazen zor konuşur.
Herkes “mucize” ister, ama biz sabırla örülmüş gerçekleri anlatırız.

📌 Evet, süreç yorucu.
📌 Evet, sonuç her zaman adil değil.
Ama geçmişe göre çok daha iyiyiz.
Birçok tümörde, yıllar kazandıran tedaviler var artık

Bugünkü kelimemiz: Radikal Prostatektomi

🧬 Prostat kanseri tedavisinde sık kullanılan bu kelime, aslında ne demek?

👨‍⚕️ Prostat bezinin tamamen çıkarıldığı bir ameliyat. Genellikle erken evredeki hastalarda uygulanır.
🎯 Bilmek güç verir.
Takipte kalın, diğer terimleri de birlikte öğrenelim.

🔬 Klinik Araştırma Nedir?
Kanser gibi ciddi hastalıklar için daha etkili, daha güvenli tedaviler geliştirmek amacıyla yürütülen bilimsel çalışmalardır.

Her klinik araştırma; hem bugünün hastalarına yeni bir tedavi seçeneği sunar,
hem de gelecekte binlerce hayatın değişmesine katkı sağlar.
#science

Biyopsi = Şüpheli dokudan parça alıp mikroskopla incelemek.
Örneğin: “Mesanedeki kitlenin ne olduğunu anlamak için biyopsi yapıldı.”

🎯 Çünkü doğru tanı, doğru tedavinin ilk adımıdır.

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer | NEJM Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. In this phase 3, randomized trial conducted at 55 centers, ...

I have two favourite studies from #ASCO25 @christielibrary.bsky.social @mcrcnews.bsky.social 👇🏽
www.nejm.org/doi/full/10....

Hypertension, Diabetes, and High Cholesterol Awareness Among US Adults This cross-sectional study evaluated the changes in the proportion of US adults who were unaware they had hypertension, diabetes, or a high cholesterol level using 2013 to 2023 data from the National ...

Our new JAMA Cardiology study finds that many US adults don't know that they have hypertension, diabetes, or high cholesterol

Nearly 1 in 3 young adults w/ hypertension, 2 in 5 with diabetes, and 1 in 4 with high cholesterol are unaware of their condition.

bit.ly/45an6MC #medsky #cardiosky

#ASMS2025 ThP046 come to check out Jenny’s poster! Don’t miss this great opportunity to meet Jenny! @asms.org @jyates.bsky.social @femalesinms.bsky.social #teammassspec @garcialabms.bsky.social @proteomicsnews.bsky.social